Inventor
LEVITZKI ALEXANDER
US41 patents
⚠️ This page may combine multiple inventors who share the name “LEVITZKI ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YISSUM RES DEV CO
15 patentsUS5217999AJun 8, 1993
Styryl compounds which inhibit EGF receptor protein tyrosine kinase
YISSUM RES DEV CO302 citations99
US5712395AJan 27, 1998
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
YISSUM RES DEV CO118 citations98
US5981569ANov 9, 1999
Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease
YISSUM RES DEV CO86 citations96
US5932580AAug 3, 1999
PDGF receptor kinase inhibitory compounds their preparation and compositions
YISSUM RES DEV CO95 citations96
US5196446AMar 23, 1993
Certain indole compounds which inhibit EGF receptor tyrosine kinase
YISSUM RES DEV CO101 citations96
US6562319B2May 13, 2003
Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
YISSUM RES DEV CO89 citations93
USRE38761EJul 19, 2005
Styryl compounds which inhibit EGF receptor protein tyrosine kinase
YISSUM RES DEV CO13 citations84
US6358954B1Mar 19, 2002
PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
YISSUM RES DEV CO16 citations80
US6673798B2Jan 6, 2004
PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
YISSUM RES DEV CO10 citations69
US5990277ANov 23, 1999
Semipeptoid farnesyl protein transferase inhibitors and analogs thereof
YISSUM RES DEV CO4 citations62
US7927792B2Apr 19, 2011
Targeted double stranded RNA mediated cell killing
YISSUM RES DEV CO2 citations61
US6949565B2Sep 27, 2005
Protein kinase inhibitors
YISSUM RES DEV CO3 citations60
US9770454B2Sep 26, 2017
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases
YISSUM RES DEV CO0 citations51
US8372818B2Feb 12, 2013
Targeted double stranded RNA mediated cell killing
YISSUM RES DEV CO1 citations51
US8044032B2Oct 25, 2011
Selective killing of cells by activation of double-stranded RNA dependent protein kinase-PKR
YISSUM RES DEV CO0 citations51
SUGEN INC
5 patentsUS5792771AAug 11, 1998
Quinazoline compounds and compositions thereof for the treatment of disease
SUGEN INC155 citations98
US5773476AJun 30, 1998
Methods and compositions for inhibiting cell proliferative disorders
SUGEN INC153 citations98
US5763441AJun 9, 1998
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
SUGEN INC111 citations97
US5849742ADec 15, 1998
Compounds for the treament of disorders related to vasculogenesis and/or angiogenesis
SUGEN INC28 citations92
US7217737B2May 15, 2007
Method and compositions for inhibiting cell proliferative disorders
SUGEN INC3 citations62
TARGIMMUNE THERAPEUTICS AG
3 patentsREUVENI HADAS
3 patentsUS8058309B2Nov 15, 2011
Protein kinase modulators and therapeutic uses thereof
REUVENI HADAS6 citations53
US9073880B2Jul 7, 2015
2-(2-phenylethenyl) 1,3-benzodiazepine derivatives useful for the treatment of cancer
REUVENI HADAS1 citations49
US8637575B2Jan 28, 2014
Modulators of protein kinase signaling
REUVENI HADAS1 citations46
RHONE POULENC RORER PHARMA
2 patentsUS5302606AApr 12, 1994
Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase
RHONE POULENC RORER PHARMA284 citations99
US5677329AOct 14, 1997
Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase
RHONE POULENC RORER PHARMA15 citations82
HADASIT MED RES SERVICE
2 patentsUS6126917AOct 3, 2000
Epidermal growth factor receptor binding compounds for positron emission tomography
HADASIT MED RES SERVICE62 citations91
US7172749B2Feb 6, 2007
Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
HADASIT MED RES SERVICE1 citations48